S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
OTCMKTS:BTCA

Bactolac Pharmaceutical Stock Forecast, Price & News

$120,000.00
0.00 (0.00 %)
(As of 09/18/2017)
Add
Compare
Today's Range
$120,000.00
$120,000.00
50-Day Range
$120,000.00
$120,000.00
52-Week Range
$120,000.00
$120,000.00
VolumeN/A
Average VolumeN/A
Market Capitalization$1.20 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.01
30 days | 90 days | 365 days | Advanced Chart
Receive BTCA News and Ratings via Email

Sign-up to receive the latest news and ratings for Bactolac Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.


Bactolac Pharmaceutical logo

About Bactolac Pharmaceutical

Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BTCA
CIK
N/A
Employees
126
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.20 billion
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Bactolac Pharmaceutical (OTCMKTS:BTCA) Frequently Asked Questions

What stocks does MarketBeat like better than Bactolac Pharmaceutical?

Wall Street analysts have given Bactolac Pharmaceutical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bactolac Pharmaceutical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Bactolac Pharmaceutical's key executives?

Bactolac Pharmaceutical's management team includes the following people:
  • Pailla Malla Reddy, Chairman, President & Chief Executive Officer
  • Hanuman Rao Davuluri, Director-Operations & Formulation Department
  • Renee Reynolds, Chief Financial Officer, Co-Secretary & VP
  • Venkat Reddy Guduru, Chief Scientific Officer
  • Gregory S. Pusey, Director & Assistant Secretary

What is Bactolac Pharmaceutical's stock symbol?

Bactolac Pharmaceutical trades on the OTCMKTS under the ticker symbol "BTCA."

How do I buy shares of Bactolac Pharmaceutical?

Shares of BTCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bactolac Pharmaceutical's stock price today?

One share of BTCA stock can currently be purchased for approximately $120,000.00.

How much money does Bactolac Pharmaceutical make?

Bactolac Pharmaceutical has a market capitalization of $1.20 billion.

How many employees does Bactolac Pharmaceutical have?

Bactolac Pharmaceutical employs 126 workers across the globe.

What is Bactolac Pharmaceutical's official website?

The official website for Bactolac Pharmaceutical is www.nnfa.org.

Where are Bactolac Pharmaceutical's headquarters?

Bactolac Pharmaceutical is headquartered at 106 SOUTH UNIVERSITY BLVD., DENVER CO, 80209.

How can I contact Bactolac Pharmaceutical?

Bactolac Pharmaceutical's mailing address is 106 SOUTH UNIVERSITY BLVD., DENVER CO, 80209. The company can be reached via phone at (631) 951-4908.


This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.